Galenica AG
- Jurisdiction
Switzerland - LEI
506700W4772BD8016Z20 - ISIN
CH0360674466 (GALE.SW )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€59.26 61.2% overvalued - Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Galenica AG operates as a healthcare service provider in Switzerland and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€8.46B - Gross margin
10.0% - EBIT
€451.03M - EBIT margin
5.3% - Net income
€400.07M - Net margin
4.7%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Dividends
- Last dividend amount
-
CHF 2.30 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
60.9%
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| N/A | N/A |
|
|
|
|
| N/A | N/A |
|
|
|
|
| N/A | N/A |
|
|
|
|
| N/A | N/A |
|
|
|
|
| N/A | N/A |
|
|
|
|